Patent Assignment Details
NOTE:Results display only for issued patents and published applications.
For pending or abandoned applications please consult USPTO staff.
|
| Reel/Frame: | 019815/0745 | |
| Pages: | 5 |
| | Recorded: | 09/12/2007 | | |
| Attorney Dkt #: | 15060/123 |
| Conveyance: | ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS). |
|
|
Total properties:
1
|
|
|
|
Patent #:
|
NONE
|
Issue Dt:
|
|
Application #:
|
11539141
|
Filing Dt:
|
10/05/2006
|
|
Publication #:
|
|
Pub Dt:
|
11/15/2007
| | | | |
|
Title:
|
ENHANCED MEDICAL TREATMENTS RESULTING FROM CHEMICAL IDENTIFICATION OF CALCIUM INFLUX FACTOR, IDENTITY WITH THE FACTOR ACTIVATING PHOSPHOLIPOLYSIS AND PRECIPITATING SUDDEN DEATH DURING MYOCARDIAL INFARCTION, AND DETERMINATION OF SIMILAR ACTIVATING MECHANISMS IN MULTIPLE CELL TYPES THROUGH DISINHIBITION OF CALCIUM-INDEPENDENT PHOSPHOLIPASE A2beta
|
|
|
Assignee
|
|
|
|
|
| 660 SOUTH EUCLID |
| ST. LOUIS, MISSOURI 63110 |
|
|
Correspondence name and address
|
| |
PATRICK W. RASCHE
|
| |
ARMSTRONG TEASDALE LLP
|
| |
ONE METROPOLITAN SQUARE, SUITE 2600
|
| |
ST. LOUIS, MO 63102
|
Search Results as of:
05/31/2024 08:58 PM
If you have any comments or questions concerning the data displayed,
contact
PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified:
August 25, 2017 v.2.6
|
